A detailed history of Baugh & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Baugh & Associates, LLC holds 50,823 shares of MRK stock, worth $5.07 Million. This represents 2.9% of its overall portfolio holdings.

Number of Shares
50,823
Previous 46,282 9.81%
Holding current value
$5.07 Million
Previous $5.73 Million 0.73%
% of portfolio
2.9%
Previous 3.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$111.15 - $128.97 $504,732 - $585,652
4,541 Added 9.81%
50,823 $5.77 Million
Q2 2024

Jul 12, 2024

SELL
$123.8 - $132.96 $265,179 - $284,800
-2,142 Reduced 4.42%
46,282 $5.73 Million
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $39,407 - $45,918
348 Added 0.72%
48,424 $6.39 Million
Q4 2023

Jan 10, 2024

SELL
$100.18 - $109.02 $66,920 - $72,825
-668 Reduced 1.37%
48,076 $5.24 Million
Q3 2023

Oct 13, 2023

SELL
$102.95 - $114.33 $22,649 - $25,152
-220 Reduced 0.45%
48,744 $5.02 Million
Q2 2023

Jul 20, 2023

BUY
$108.61 - $118.38 $85,258 - $92,928
785 Added 1.63%
48,964 $5.65 Million
Q1 2023

Apr 27, 2023

SELL
$102.94 - $114.86 $110,763 - $123,589
-1,076 Reduced 2.18%
48,179 $5.13 Million
Q4 2022

Jan 27, 2023

SELL
$87.44 - $112.11 $6,558 - $8,408
-75 Reduced 0.15%
49,255 $0
Q3 2022

Oct 07, 2022

SELL
$84.53 - $94.96 $5,071 - $5,697
-60 Reduced 0.12%
49,330 $4.25 Million
Q2 2022

Jul 19, 2022

SELL
$83.49 - $94.64 $45,084 - $51,105
-540 Reduced 1.08%
49,390 $4.5 Million
Q1 2022

Apr 20, 2022

SELL
$73.51 - $82.4 $11,761 - $13,184
-160 Reduced 0.32%
49,930 $4.1 Million
Q4 2021

Jan 14, 2022

BUY
$72.28 - $90.54 $361 - $452
5 Added 0.01%
50,090 $3.84 Million
Q3 2021

Oct 13, 2021

SELL
$71.68 - $78.83 $2,078 - $2,286
-29 Reduced 0.06%
50,085 $3.76 Million
Q2 2021

Jul 12, 2021

SELL
$70.31 - $77.77 $32,342 - $35,774
-460 Reduced 0.91%
50,114 $3.9 Million
Q1 2021

Apr 16, 2021

SELL
$68.86 - $81.11 $413 - $486
-6 Reduced 0.01%
50,574 $3.9 Million
Q4 2020

Jan 13, 2021

SELL
$71.77 - $79.65 $44,497 - $49,383
-620 Reduced 1.21%
50,580 $4.14 Million
Q3 2020

Oct 28, 2020

SELL
$73.18 - $82.95 $47,201 - $53,502
-645 Reduced 1.24%
51,200 $4.25 Million
Q2 2020

Jul 09, 2020

BUY
$70.42 - $80.13 $254,357 - $289,429
3,612 Added 7.49%
51,845 $4.01 Million
Q1 2020

Apr 21, 2020

SELL
$63.36 - $87.82 $89,971 - $124,704
-1,420 Reduced 2.86%
48,233 $3.71 Million
Q4 2019

Jan 13, 2020

SELL
$77.58 - $87.54 $39,255 - $44,295
-506 Reduced 1.01%
49,653 $4.52 Million
Q3 2019

Oct 08, 2019

SELL
$76.08 - $82.93 $15,216 - $16,586
-200 Reduced 0.4%
50,159 $4.22 Million
Q2 2019

Jul 23, 2019

SELL
$69.84 - $81.59 $24,094 - $28,148
-345 Reduced 0.68%
50,359 $4.22 Million
Q1 2019

Apr 05, 2019

SELL
$69.58 - $79.36 $26,092 - $29,760
-375 Reduced 0.73%
50,704 $4.22 Million
Q4 2018

Jan 17, 2019

SELL
$65.24 - $75.71 $5,414 - $6,283
-83 Reduced 0.16%
51,079 $3.9 Million
Q3 2018

Nov 02, 2018

SELL
$57.69 - $67.84 $34,614 - $40,704
-600 Reduced 1.16%
51,162 $3.63 Million
Q2 2018

Jul 27, 2018

SELL
$50.83 - $59.72 $239,307 - $281,161
-4,708 Reduced 8.34%
51,762 $3.14 Million
Q1 2018

Apr 25, 2018

BUY
$50.96 - $59.23 $2.88 Million - $3.34 Million
56,470 New
56,470 $3.08 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Baugh & Associates, LLC Portfolio

Follow Baugh & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baugh & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baugh & Associates, LLC with notifications on news.